 HTG Molecular Diagnostics, Inc. HTGM HTG, a life science company whose mission is to advance precision medicine, today announced that it has entered into a 10.0 million senior term loan agreement with Silicon Valley Bank SVB, the bank of the worlds most innovative companies and their investors, to replace its existing senior credit facility. Proceeds from the 10.0 million senior term loan have been used to pay off HTGs outstanding 7.0 million principal amount term loan with MidCap Financial and its 3.0 million principal amount subordinated convertible promissory note held by Qiagen North American Holdings, Inc. The duration of the senior term loan is 42 months, with interest only payments through June 30, 2021 plus 6 additional months under certain conditions. 